EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Feasibility of Direct Oral Anticoagulant Dipstick Point-of-Care Testing in Patients with Acute Stroke and Transient Ischaemic Attack

Maximilian Ziegler, Kristina Szabo, Carolin Hoyer, Olaf Willmann, Adrian Bursa, Job Harenberg, Uwe Spannagel, Svetlana Hetjens, Christel Weiss, Rolf Kern

Cerebrovascular Diseases Extra · 09.06.2026 · 16 (1) · 194-205

DOI: 10.1159/000552560 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cerebrovascular Diseases Extra, online erschienen am 09.06.2026. Verfasst von Maximilian Ziegler und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany, maxziegler96.mz@gmail.com. Hauptthemen laut MEDLINE: Ischemic Attack, Transient, Point-of-Care Testing, Stroke, Factor Xa Inhibitors. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In patients with acute stroke, the plasma concentrations of direct oral anticoagulants (DOACs) need to be known for further treatment decisions. The point-of-care test DOAC Dipstick contains two test pads that determine levels of direct factor Xa (FXA) inhibitors and thrombin (THR) inhibitors in urine samples; thereby determining DOAC plasma levels of >30 ng/mL within 10 min. This study aimed to test the feasibility of using the DOAC Dipstick to detect the presence of DOACs in patients with acute stroke and transient ischaemic attack (TIA) during the early phase of intrahospital stroke management.

Methods

Urine samples from patients with acute stroke and TIA with or without DOAC intake were obtained within 8 h after hospitalisation. The urine samples were tested using the DOAC Dipstick. After incubation, colour change on the DOAC Dipstick pads were analysed visually and using a semi-automated reader. Primary endpoints were the success rate of evaluable pad results and time to results after urine sampling.

Results

From January 2023 to April 2024, 70 patients were recruited, 66 of whom fulfilled the inclusion criteria (39% female, mean age 73 ± 11.9 years). The median (interquartile range) times from urine sample collection to visual and reader test pad results were 20 (15–26) min and 24 (16–37) min, respectively. The test procedure was uncomplicated in most patients (n = 60). Complications in the test procedure were delays in urine sampling (n = 3), need for repeated testing due to dry strip (n = 2), no visual evaluability of the test result (n = 1), and abnormal urine colour (n = 1). The urine samples of all patients with prior DOAC intake (n = 26) were positive for DOACs while those for all patients without prior DOAC intake (n = 39) were negative for DOACs (1 patient was excluded because the urine sample was not collected in time).

Conclusion

The DOAC Dipstick rapidly and reliably detects DOACs in urine samples from patients with acute stroke and TIA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic Attack, TransientPoint-of-Care TestingStrokeFactor Xa InhibitorsReagent StripsDrug MonitoringUrinalysisHumansFemaleFeasibility StudiesAgedMaleAdministration, OralAged, 80 and overPredictive Value of TestsTime FactorsMiddle AgedBiomarkersReproducibility of ResultsRapid Diagnostic Tests

Stichwörter der Autor:innen

Direct oral anticoagulant-dipstickDirect oral anticoagulantsPoint-of-care testingStrokeTransient ischaemic attack

Substanzen

Factor Xa InhibitorsReagent StripsBiomarkers

Autor:innen und Institutionen

  • Department of Neurology, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany, maxziegler96.mz@gmail.com.
  • Department of Neurology, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
  • Department of Neurology, Klinikum Worms gGmbH, Worms, Germany.
  • DOASENSE GmbH, Heidelberg, Germany.
  • Biometry and Biomathematics, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.

Zitieren

APA

Ziegler, M., Szabo, K., Hoyer, C., Willmann, O., Bursa, A., Harenberg, J., Spannagel, U., Hetjens, S., Weiss, C., & Kern, R. (2026). Feasibility of Direct Oral Anticoagulant Dipstick Point-of-Care Testing in Patients with Acute Stroke and Transient Ischaemic Attack. Cerebrovascular Diseases Extra, 16(1), 194-205. https://doi.org/10.1159/000552560

Vancouver

Ziegler M, Szabo K, Hoyer C, Willmann O, Bursa A, Harenberg J, et al. Feasibility of Direct Oral Anticoagulant Dipstick Point-of-Care Testing in Patients with Acute Stroke and Transient Ischaemic Attack. Cerebrovascular Diseases Extra. 2026;16(1):194-205. doi:10.1159/000552560

BibTeX
@article{Ziegler2026,
  author = {Ziegler, Maximilian and Szabo, Kristina and Hoyer, Carolin and Willmann, Olaf and Bursa, Adrian and Harenberg, Job and Spannagel, Uwe and Hetjens, Svetlana and Weiss, Christel and Kern, Rolf},
  title = {Feasibility of Direct Oral Anticoagulant Dipstick Point-of-Care Testing in Patients with Acute Stroke and Transient Ischaemic Attack},
  journal = {Cerebrovascular Diseases Extra},
  year = {2026},
  volume = {16},
  number = {1},
  pages = {194--205},
  doi = {10.1159/000552560}
}
Kostenlos starten →